Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar Haugurafpeningum (81.94) Submitted: 11/8/2011 2:36:40 AM : Outperform Start Price: $1.52 ALTH Score: +13.19

Technical Monthly

Report this Post Reply

Featured Broker Partners


Advertisement